-
EXCLUSIVE: Hoth Therapeutics Speaks To Benzinga As Stock Spikes Over 90% On Newly Released Proof-Of-Concept Data
Tuesday, January 4, 2022 - 5:21pm | 438Read More...Hoth Therapeutics Inc (NASDAQ: HOTH) shares are soaring Tuesday after the company highlighted proof-of-concept data generated using an Alzheimer's disease mouse model, supporting the therapeutic potential of HT-ALZ, a therapeutic in development for the treatment of dementia...
